Skip to main content

Hyperandrogenism secondary to topical testosterone exposure

Topical testosterone gels are now a widely used method of testosterone replacement therapy and have been shown to be convenient and effective[1]. The unintentional transfer of testosterone gel to children or partners by skin contact is a rare but significant adverse effect[2].

A 3-year-old well girl was referred for assessment of precocious puberty. Pubic hair had been first noted by her mother 9 months earlier. Examination revealed a tall girl (>99.9th centile) with no breast development but Tanner stage III pubic hair and cliteromegaly. Testosterone levels were elevated at 2.5nmol/l, as was her Androstenedione level at 1.1nmol/l. 17 OH P was normal and tumour markers were negative. Urine steroid profile was quantitatively normal but there was a modest increase in androgen metabolites. Bone age was advanced by 16 months. Ultrasound and MRI imaging of her ovaries and adrenals did not reveal a source of androgen production.

Upon further direct questioning, her father revealed he was using topical testosterone replacement therapy. Her father was advised of measures to reduce secondary exposure. Her repeat testosterone level fell to <0.7 nmol/l upon retesting 4 months later and the cliteromegaly resolved. At follow up a further six months later, testosterone level had risen to 2.5nmol/l. Switching to the use of IM preparations was encouraged. Follow-up testing after these measures were adopted revealed normal undetectable testosterone levels (<0.7nmol/l).

Once daily application of testosterone gels to the skin results in relatively stable and physiological testosterone levels in most users[3]. It is often favoured above the other methods of delivery of testosterone as it is painless, discrete and convenient to use. Even small quantities of transferred testosterone may result in clinical signs of hyperandrogenism.

When reviewing children with evidence of virilization, we must remember to question parents about the potential for exogenous androgen exposure.


  1. 1.

    McNicholas TA: A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int. 2003, 91 (1): 69-74. 10.1046/j.1464-410X.2003.04016.x.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Kunz GJ: Virilization of young children after topical androgen use by their parents. Pediatrics. 2004, 114 (1): 282-4. 10.1542/peds.114.1.282.

    Article  PubMed  Google Scholar 

  3. 3.

    Steidle C: AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab. 2003, 88 (6): 2673-81.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to A Carroll.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Carroll, A., Moloney, S. & Murphy, N. Hyperandrogenism secondary to topical testosterone exposure. Int J Pediatr Endocrinol 2013, P66 (2013).

Download citation

  • Published:

  • DOI:


  • Testosterone
  • Androgen
  • Testosterone Level
  • Precocious Puberty
  • Hyperandrogenism